Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1Appendiceal Neoplasms 1Adenocarcinoma, Mucinous 1

Interventions

Mitomycin 9Oxaliplatin 7Hyperthermic Intraperitoneal Chemotherapy 7Leucovorin 5Irinotecan 5Fluorouracil 4Surveys and Questionnaires 3Cisplatin 3Capecitabine 3dehydroftorafur 2Thalidomide 2Mitozytrex 2Doxorubicin 2Cytoreduction Surgical Procedures 2Biopsy 2surufatinib 1sintilimab 1nintedanib 1irinotecan sucrosofate 1durvalumab 1Yoga 1Watchful Waiting 1Surgical Procedures, Operative 1Specimen Handling 1Referral and Consultation 1Psychiatric Rehabilitation 1Platinum 1Pharmacogenomic Testing 1Palonosetron 1Pafolacianine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Appendiceal Neoplasms × DNA Fingerprinting × Clear all
NCT05734430 2025-04-18

GAP

Vanderbilt-Ingram Cancer Center

Recruiting
700 enrolled
Gastrointestinal

Appendiceal Neoplasms, Adenocarcinoma, Mucinous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡